Induction of heme oxygenase-1 shifts the balance from proinjury to prosurvival in the placentas of pregnant rats with reduced uterine perfusion pressure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 5, 2012, Pages

  George, Eric M ^a   Arany, Istvan ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Extracellular signal regulated kinase; Heme oxygenase 1; Janus activated kinase; Preeclampsia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P52; STAT1 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONCENTRATION (PARAMETERS); ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; FEMALE; GESTATIONAL AGE; ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PERFUSION PRESSURE; PHENOTYPE; PLACENTA ISCHEMIA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RAT; REDUCED UTERINE PERFUSION PRESSURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CASPASE 3; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HEME OXYGENASE-1; ISCHEMIA; MAP KINASE KINASE 4; MODELS, ANIMAL; OXIDATIVE STRESS; PHOSPHORYLATION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, ANIMAL; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; UTERUS;

EID: 84857893779     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00617.2011     Document Type: Article

References (54)

1. Alexander BT, Cockrell K, Cline FD, Llinas MT, Sedeek M, Granger JP. Effect of angiotensin II synthesis blockade on the hypertensive response to chronic reductions in uterine perfusion pressure in pregnant rats. Hypertension 38: 742-745, 2001.
2. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37: 1191-1195, 2001.
3. Arany I, Faisal A, Nagamine Y, Safirstein RL. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem 283: 6110-6117, 2008.
4. Arany I, Megyesi JK, Kaneto H, Tanaka S, Safirstein RL. Activation of ERK or inhibition of JNK ameliorates H2O2 cytotoxicity in mouse renal proximal tubule cells. Kidney Int 65: 1231-1239, 2004.
5. Botros FT, Schwartzman ML, Stier CT, Goodman AI, Abraham NG. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 68: 2745-2755, 2005.
6. Cao J, Inoue K, Li X, Drummond G, Abraham NG. Physiological significance of heme oxygenase in hypertension. Int J Biochem Cell Biol 41: 1025-1033, 2009.
7. Cindrova-Davies T. Gabor Than Award Lecture 2008: pre-eclampsia: from placental oxidative stress to maternal endothelial dysfunction. Placenta 30, Suppl. A: S55-S65, 2009.
8. Clark JS, Faisal A, Baliga R, Nagamine Y, Arany I. Cisplatin induces apoptosis through the ERK-p66shc pathway in renal proximal tubule cells. Cancer Lett 297: 165-170, 2010.
9. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endo-thelium-dependent vascular relaxation during reduction of uterine perfu-sion pressure in pregnant rat. Hypertension 35: 367-372, 2000.
10. Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48: 41-47, 1999.
11. di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol Renal Physiol 277: F195-F203, 1999.
12. Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev 12: 181-188, 2007.
13. George EM, Arany M, Cockrell K, Storm MV, Stec DE, Granger JP. Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 301: R1495-R1500, 2011.
14. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57: 941-948, 2011.
15. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57: 941-948, 2011.
16. George EM, Colson D, Dixon J, Palei AC, Granger JP. Heme oxygen-ase-1 attenuates hypoxia-induced sFlt-1 and oxidative stress in placental villi through its metabolic products CO and bilirubin. Int J Hypertens 2012: 486053, 2012.
17. George EM, Granger JP. Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol 5: 557-566, 2010.
18. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 50: 323-354, 2010.
19. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 122: 383-392, 2006.
20. Heltemes A, Gingery A, Soldner EL, Bozadjieva N, Jahr KN, Johnson BK, Gilbert JS. Chronic placental ischemia alters amniotic fluid milieu and results in impaired glucose tolerance, insulin resistance and hyperlep-tinemia in young rats. Exp Biol Med (Maywood) 235: 892-899, 2010.
21. Herse F, Staff AC, Hering L, Muller DN, Luft FC, Dechend R. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med 86: 697-703, 2008.
22. Hilfiker-Kleiner D, Hilfiker A, Drexler H. Many good reasons to have STAT3 in the heart. Pharmacol Ther 107: 131-137, 2005.
23. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2: 543-549, 2007.
24. Jiang K, Cheng L, Wang J, Li J, Nie J. Heme oxygenase-1 expression in rats with acute lung rejection and implication. J Huazhong Univ Sci Technolog Med Sci 29: 84-87, 2009.
25. Khan AU, Wilson T. Reactive oxygen species as cellular messengers. Chem Biol 2: 437-445, 1995.
26. Khong Y, Brosens I. Defective deep placentation. Best Pract Res Clin Obstet Gynaecol 25: 301-311, 2011.
27. Kurdi M, Booz GW. Deciphering STAT3 signaling in the heart: plasticity and vascular inflammation. Congest Heart Fail 16: 234-238, 2010.
28. Lin HY, Shen SC, Lin CW, Wu MS, Chen YC. Cobalt protoporphyrin inhibition of lipopolysaccharide or lipoteichoic acid-induced nitric oxide production via blocking c-Jun N-terminal kinase activation and nitric oxide enzyme activity. Chem Biol Interact 180: 202-210, 2009.
29. Luzi L, Confalonieri S, Di Fiore PP, Pelicci PG. Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 10: 668-674, 2000.
30. Migliaccio E, Mele S, Salcini Anna E, Pelicci G, Lai KMan V, Superti-Furga G, Pawson T, Paolo Di Fiore P, Lanfrancone L, Pelicci PG. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 16: 706-716, 1997.
31. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 178: 2623-2629, 2007.
32. Nusken KD, Dotsch J, Rauh M, Rascher W, Schneider H. Uteropla-cental insufficiency after bilateral uterine artery ligation in the rat: impact on postnatal glucose and lipid metabolism and evidence for metabolic programming of the offspring by sham operation. Endocrinology 149: 1056-1063, 2008.
33. Owuor ED, Kong AN. Antioxidants and oxidants regulated signal trans-duction pathways. Biochem Pharmacol 64: 765-770, 2002.
34. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 26: 3100-3112, 2007.
35. Rao GN. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein ki-nases. Oncogene 13: 713-719, 1996.
36. Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene 20: 6322-6330, 2001.
37. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 41: 437-445, 2003.
38. Rosa AO, Egea J, Lorrio S, Rojo AI, Cuadrado A, Lopez MG. Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt pro-toporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice. Pain 137: 332-339, 2008.
39. Sabaawy HE, Zhang F, Nguyen X, ElHosseiny A, Nasjletti A, Schwartzman M, Dennery P, Kappas A, Abraham NG. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 38: 210-215, 2001.
40. Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens 21: 1152-1156, 2008.
41. Sharp AN, Heazell AE, Crocker IP, Mor G. Placental apoptosis in health and disease. Am J Reprod Immunol 64: 159-169, 2010.
42. Shin JK, Jeong YT, Jo HC, Kang MY, Chang IS, Baek JC, Park JK, Lee SA, Lee JH, Choi WS, Paik WY. Increased interaction between heat shock protein 27 and mitogen-activated protein kinase (p38 and extracellular signal-regulated kinase) in pre-eclamptic placentas. J Obstet Gynae-col Res 35: 888-894, 2009.
43. Sholook MM, Gilbert JS, Sedeek MH, Huang M, Hester RL, Granger JP. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Physiol Heart Circ Physiol 293: H2080-H2084, 2007.
44. Staff AC, Halvorsen B, Ranheim T, Henriksen T. Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with pre-eclampsia. Am J Obstet Gynecol 181: 1211-1215, 1999.
45. Staff AC, Ranheim T, Khoury J, Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 180: 587-592, 1999.
46. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
47. Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, Morita K, Sassa S. Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem 7: 745-753, 2007.
48. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
49. Tsuchihashi S, Zhai Y, Bo Q, Busuttil RW, Kupiec-Weglinski JW. Heme oxygenase-1 mediated cytoprotection against liver ischemia and reperfusion injury: inhibition of type-1 interferon signaling. Transplantation 83: 1628-1634, 2007.
50. Wagner M, Siddiqui MA. Signaling networks regulating cardiac myo-cyte survival and death. Curr Opin Investig Drugs 10: 928-937, 2009.
51. Xia Y, Kellems RE. Is preeclampsia an autoimmune disease? Clin Immunol 133: 1-12, 2009.
52. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
53. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci 98: 9050-9055, 2001.
54. Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, Abraham NG. Heme oxygenase-1 gene expression modulates angiotensin II-in-duced increase in blood pressure. Hypertension 43: 1221-1226, 2004.